Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Segmentation of Glomeruli Within Trichrome Images Using Deep Learning.

Kannan S, Morgan LA, Liang B, Cheung MG, Lin CQ, Mun D, Nader RG, Belghasem ME, Henderson JM, Francis JM, Chitalia VC, Kolachalama VB.

Kidney Int Rep. 2019 Apr 15;4(7):955-962. doi: 10.1016/j.ekir.2019.04.008. eCollection 2019 Jul.

2.

Emerging Factors Implicated in Fibrotic Organ-Associated Thrombosis: The Case of Two Organs.

Leiva O, Bekendam RH, Garcia BD, Thompson C, Cantor A, Chitalia V, Ravid K.

TH Open. 2019 Jun 7;3(2):e165-e170. doi: 10.1055/s-0039-1692204. eCollection 2019 Apr. Review.

3.

c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis.

Lyle CL, Belghasem M, Chitalia VC.

Cells. 2019 May 23;8(5). pii: E498. doi: 10.3390/cells8050498. Review.

4.

Towards minimally-invasive, quantitative assessment of chronic kidney disease using optical spectroscopy.

Belghasem ME, A'amar O, Roth D, Walker J, Arinze N, Richards SM, Francis JM, Salant DJ, Chitalia VC, Bigio IJ.

Sci Rep. 2019 May 9;9(1):7168. doi: 10.1038/s41598-019-43684-8.

5.

Intrinsic coating morphology modulates acute drug transfer in drug-coated balloon therapy.

Chang GH, Azar DA, Lyle C, Chitalia VC, Shazly T, Kolachalama VB.

Sci Rep. 2019 May 2;9(1):6839. doi: 10.1038/s41598-019-43095-9.

6.

Unique aspects of peripheral artery disease in patients with chronic kidney disease.

Arinze NV, Gregory A, Francis JM, Farber A, Chitalia VC.

Vasc Med. 2019 Jun;24(3):251-260. doi: 10.1177/1358863X18824654. Epub 2019 Mar 1. Review.

PMID:
30823859
7.

Efficiency of Biosynthesized Silver and Zinc Nanoparticles Against Multi-Drug Resistant Pathogens.

Punjabi K, Mehta S, Chavan R, Chitalia V, Deogharkar D, Deshpande S.

Front Microbiol. 2018 Sep 20;9:2207. doi: 10.3389/fmicb.2018.02207. eCollection 2018.

8.

c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation.

Kumaradevan S, Lee SY, Richards S, Lyle C, Zhao Q, Tapan U, Jiangliu Y, Ghumman S, Walker J, Belghasem M, Arinze N, Kuhnen A, Weinberg J, Francis J, Hartshorn K, Kolachalama VB, Cifuentes D, Rahimi N, Chitalia VC.

Am J Pathol. 2018 Aug;188(8):1921-1933. doi: 10.1016/j.ajpath.2018.05.007. Epub 2018 Jul 17.

9.

Matrix-Embedded Endothelial Cells Attain a Progenitor-Like Phenotype.

Abraham E, Gadish O, Franses JW, Chitalia VC, Artzi N, Edelman ER.

Adv Biosyst. 2017 Sep;1(9). pii: 1700057. doi: 10.1002/adbi.201700057. Epub 2017 Jul 20.

10.

Concurrent Presentation of Thrombotic Thrombocytopenic Purpura and Membranous Nephropathy.

Al-Rabadi L, Quillen K, Shashar M, Al Marji C, Jaberi A, Chitalia V, Henderson J, Salant D, Beck LH Jr.

Kidney Int Rep. 2017 Aug 19;3(2):476-481. doi: 10.1016/j.ekir.2017.08.005. eCollection 2018 Mar. No abstract available.

11.

Association of Pathological Fibrosis With Renal Survival Using Deep Neural Networks.

Kolachalama VB, Singh P, Lin CQ, Mun D, Belghasem ME, Henderson JM, Francis JM, Salant DJ, Chitalia VC.

Kidney Int Rep. 2018 Jan 11;3(2):464-475. doi: 10.1016/j.ekir.2017.11.002. eCollection 2018 Mar.

12.

Hepatitis C virus infection in kidney transplantation-changing paradigms with novel agents.

Reddy YNV, Nunes D, Chitalia V, Gordon CE, Francis JM.

Hemodial Int. 2018 Apr;22 Suppl 1:S53-S60. doi: 10.1111/hdi.12659. Review.

PMID:
29694721
13.

Uremic Solute-Aryl Hydrocarbon Receptor-Tissue Factor Axis Associates with Thrombosis after Vascular Injury in Humans.

Kolachalama VB, Shashar M, Alousi F, Shivanna S, Rijal K, Belghasem ME, Walker J, Matsuura S, Chang GH, Gibson CM, Dember LM, Francis JM, Ravid K, Chitalia VC.

J Am Soc Nephrol. 2018 Mar;29(3):1063-1072. doi: 10.1681/ASN.2017080929. Epub 2018 Jan 17.

14.

Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.

Shashar M, Belghasem ME, Matsuura S, Walker J, Richards S, Alousi F, Rijal K, Kolachalama VB, Balcells M, Odagi M, Nagasawa K, Henderson JM, Gautam A, Rushmore R, Francis J, Kirchhofer D, Kolandaivelu K, Sherr DH, Edelman ER, Ravid K, Chitalia VC.

Sci Transl Med. 2017 Nov 22;9(417). pii: eaam8475. doi: 10.1126/scitranslmed.aam8475.

15.

Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy.

Woolf N, Pearson BE, Bondzie PA, Meyer RD, Lavaei M, Belkina AC, Chitalia V, Rahimi N.

Oncogenesis. 2017 Sep 18;6(9):e378. doi: 10.1038/oncsis.2017.77.

16.

Thrombotic Microangiopathy: A Multidisciplinary Team Approach.

Gordon CE, Chitalia VC, Sloan JM, Salant DJ, Coleman DL, Quillen K, Ravid K, Francis JM.

Am J Kidney Dis. 2017 Nov;70(5):715-721. doi: 10.1053/j.ajkd.2017.05.017. Epub 2017 Jul 15.

PMID:
28720207
17.

Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis.

Abbonante V, Chitalia V, Rosti V, Leiva O, Matsuura S, Balduini A, Ravid K.

Blood. 2017 Aug 10;130(6):829-831. doi: 10.1182/blood-2017-04-777417. Epub 2017 Jun 7. No abstract available.

18.

Racial differences in colorectal cancer survival at a safety net hospital.

Tapan U, Lee SY, Weinberg J, Kolachalama VB, Francis J, Charlot M, Hartshorn K, Chitalia V.

Cancer Epidemiol. 2017 Aug;49:30-37. doi: 10.1016/j.canep.2017.05.003. Epub 2017 May 21.

19.

Evaluation of HiaureusTM Coagulase Confirmation Kit in Identification of Staphylococcus aureus.

Subramanian A, Chitalia VK, Bangera K, Vaidya SP, Warke R, Chowdhary A, Deshmukh RA.

J Clin Diagn Res. 2017 Feb;11(2):DC08-DC13. doi: 10.7860/JCDR/2017/24021.9265. Epub 2017 Feb 1.

20.

A mass spectrometric method for quantification of tryptophan-derived uremic solutes in human serum.

Zhang A, Rijal K, Ng SK, Ravid K, Chitalia V.

J Biol Methods. 2017;4(3). pii: e75. doi: 10.14440/jbm.2017.182. Epub 2017 Jul 31.

21.

c-Cbl mediates the degradation of tumorigenic nuclear β-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors.

Shashar M, Siwak J, Tapan U, Lee SY, Meyer RD, Parrack P, Tan J, Khatami F, Francis J, Zhao Q, Hartshorn K, Kolachalama VB, Rahimi N, Chitalia V.

Oncotarget. 2016 Nov 1;7(44):71136-71150. doi: 10.18632/oncotarget.12107.

22.

TMIGD1 is a novel adhesion molecule that protects epithelial cells from oxidative cell injury.

Arafa E, Bondzie PA, Rezazadeh K, Meyer RD, Hartsough E, Henderson JM, Schwartz JH, Chitalia V, Rahimi N.

Am J Pathol. 2015 Oct;185(10):2757-67. doi: 10.1016/j.ajpath.2015.06.006. Epub 2015 Sep 2.

23.

Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis.

Srinivasan S, Chitalia V, Meyer RD, Hartsough E, Mehta M, Harrold I, Anderson N, Feng H, Smith LE, Jiang Y, Costello CE, Rahimi N.

Angiogenesis. 2015 Oct;18(4):449-62. doi: 10.1007/s10456-015-9468-3. Epub 2015 Jun 10.

24.

The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia.

Shivanna S, Kolandaivelu K, Shashar M, Belghasim M, Al-Rabadi L, Balcells M, Zhang A, Weinberg J, Francis J, Pollastri MP, Edelman ER, Sherr DH, Chitalia VC.

J Am Soc Nephrol. 2016 Jan;27(1):189-201. doi: 10.1681/ASN.2014121241. Epub 2015 May 27.

25.

The c-Cbl ubiquitin ligase regulates nuclear β-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway.

Shivanna S, Harrold I, Shashar M, Meyer R, Kiang C, Francis J, Zhao Q, Feng H, Edelman ER, Rahimi N, Chitalia VC.

J Biol Chem. 2015 May 15;290(20):12537-46. doi: 10.1074/jbc.M114.616623. Epub 2015 Mar 17.

26.

Muscles Protect the Kidneys.

Chitalia V.

Sci Transl Med. 2014 Dec 24;6(268). pii: 268ec219. doi: 10.1126/scitranslmed.aaa3464. No abstract available.

27.

A Tug of War in the Periphery.

Chitalia V.

Sci Transl Med. 2014 Nov 12;6(262). pii: 262ec194. doi: 10.1126/scitranslmed.aaa2061. No abstract available.

28.

Keeping the Flow Going: FGFR1 Protects Vascular Patency by Inhibiting Occlusive Neointimal Hyperplasia.

Chitalia V.

Sci Transl Med. 2014 Oct 15;6(258). pii: 258ec178. doi: 10.1126/scitranslmed.aaa0481. No abstract available.

29.

AHR: A Temple of Tolerance to Toxemia.

Chitalia V.

Sci Transl Med. 2014 Aug 20;6(250). pii: 250ec142. doi: 10.1126/scitranslmed.3010122. No abstract available.

30.

α-Ketoglutarate-A New Currency of Longevity.

Chitalia V.

Sci Transl Med. 2014 Jul 9;6(244). pii: 244ec117. doi: 10.1126/scitranslmed.3009803. No abstract available.

31.

Thrombosis in the uremic milieu--emerging role of "thrombolome".

Shashar M, Francis J, Chitalia V.

Semin Dial. 2015 Mar-Apr;28(2):198-205. doi: 10.1111/sdi.12255. Epub 2014 Jun 24. Review.

32.

Inflammatory Web Catches Vessels.

Chitalia V.

Sci Transl Med. 2014 Apr 16;6(232). pii: 232ec67. doi: 10.1126/scitranslmed.3009248. No abstract available.

33.

Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow.

Voyvodic PL, Min D, Liu R, Williams E, Chitalia V, Dunn AK, Baker AB.

J Biol Chem. 2014 Apr 4;289(14):9547-59. doi: 10.1074/jbc.M113.541573. Epub 2014 Feb 19.

34.

Lysine methylation promotes VEGFR-2 activation and angiogenesis.

Hartsough EJ, Meyer RD, Chitalia V, Jiang Y, Marquez VE, Zhdanova IV, Weinberg J, Costello CE, Rahimi N.

Sci Signal. 2013 Dec 3;6(304):ra104. doi: 10.1126/scisignal.2004289.

35.

c-Cbl, a ubiquitin E3 ligase that targets active β-catenin: a novel layer of Wnt signaling regulation.

Chitalia V, Shivanna S, Martorell J, Meyer R, Edelman E, Rahimi N.

J Biol Chem. 2013 Aug 9;288(32):23505-17. doi: 10.1074/jbc.M113.473801. Epub 2013 Jun 6.

36.

Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis.

Franses JW, Drosu NC, Gibson WJ, Chitalia VC, Edelman ER.

Int J Cancer. 2013 Sep 15;133(6):1334-44. doi: 10.1002/ijc.28146. Epub 2013 Apr 8.

37.

Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.

Chitalia VC, Shivanna S, Martorell J, Balcells M, Bosch I, Kolandaivelu K, Edelman ER.

Circulation. 2013 Jan 22;127(3):365-76. doi: 10.1161/CIRCULATIONAHA.112.118174. Epub 2012 Dec 25.

38.

Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1.

Foy RL, Chitalia VC, Panchenko MV, Zeng L, Lopez D, Lee JW, Rana SV, Boletta A, Qian F, Tsiokas L, Piontek KB, Germino GG, Zhou MI, Cohen HT.

Hum Mol Genet. 2012 Dec 15;21(26):5456-71. doi: 10.1093/hmg/dds391. Epub 2012 Sep 21.

39.

Matrix-embedded endothelial cells are protected from the uremic milieu.

Chitalia VC, Murikipudi S, Indolfi L, Rabadi L, Valdez R, Franses JW, Edelman ER.

Nephrol Dial Transplant. 2011 Dec;26(12):3858-65. doi: 10.1093/ndt/gfr337. Epub 2011 Jul 27.

40.

Stromal endothelial cells directly influence cancer progression.

Franses JW, Baker AB, Chitalia VC, Edelman ER.

Sci Transl Med. 2011 Jan 19;3(66):66ra5. doi: 10.1126/scitranslmed.3001542.

41.

Smooth muscle cells orchestrate the endothelial cell response to flow and injury.

Balcells M, Martorell J, Olivé C, Santacana M, Chitalia V, Cardoso AA, Edelman ER.

Circulation. 2010 May 25;121(20):2192-9. doi: 10.1161/CIRCULATIONAHA.109.877282. Epub 2010 May 10.

42.

Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL.

Chitalia VC, Foy RL, Bachschmid MM, Zeng L, Panchenko MV, Zhou MI, Bharti A, Seldin DC, Lecker SH, Dominguez I, Cohen HT.

Nat Cell Biol. 2008 Oct;10(10):1208-16. doi: 10.1038/ncb1781. Epub 2008 Sep 21.

43.

Role of Jade-1 in the histone acetyltransferase (HAT) HBO1 complex.

Foy RL, Song IY, Chitalia VC, Cohen HT, Saksouk N, Cayrou C, Vaziri C, Côté J, Panchenko MV.

J Biol Chem. 2008 Oct 24;283(43):28817-26. doi: 10.1074/jbc.M801407200. Epub 2008 Aug 6.

44.

Jade-1, a candidate renal tumor suppressor that promotes apoptosis.

Zhou MI, Foy RL, Chitalia VC, Zhao J, Panchenko MV, Wang H, Cohen HT.

Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11035-40. Epub 2005 Jul 26.

45.

Is peritoneal dialysis adequate for hypercatabolic acute renal failure in developing countries?

Chitalia VC, Almeida AF, Rai H, Bapat M, Chitalia KV, Acharya VN, Khanna R.

Kidney Int. 2002 Feb;61(2):747-57.

46.

Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio.

Chitalia VC, Kothari J, Wells EJ, Livesey JH, Robson RA, Searle M, Lynn KL.

Clin Nephrol. 2001 Jun;55(6):436-47.

PMID:
11434354
47.

Acute renal failure in a renal transplant donor due to primary antiphospholipid syndrome.

Chitalia VC, Kolhe N, Kothari J, Almeida AF.

Am J Nephrol. 2001 Jan-Feb;21(1):55-7.

PMID:
11275634
48.

Predicting renal survival in primary focal glomerulosclerosis from the time of presentation.

Chitalia VC, Wells JE, Robson RA, Searle M, Lynn KL.

Kidney Int. 1999 Dec;56(6):2236-42.

49.

Minimal change nephrosis and antiphospholipid antibodies: coincidental or associated?

Chitalia VC, Almeida AF, Krishnan M, Chauhan SK, Khetan PP.

Nephrol Dial Transplant. 1998 Dec;13(12):3275-6. No abstract available.

PMID:
9870515
50.

Dyslipidemia in chronic renal failure patients.

Almeida AF, Gunjotikar RV, Chitalia V.

J Postgrad Med. 1994 Apr-Jun;40(2):52-4. Review. No abstract available.

Supplemental Content

Loading ...
Support Center